Alzheimer’s drug FDA approval spurs optimism—and some caution

  • 📰 NatGeo
  • ⏱ Reading Time:
  • 45 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 51%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

The accelerated approval of a drug that promises to attack Alzheimer’s at its root offers great hope for millions of people suffering from the disease—but a number of scientists have raised concerns

of a phase 3 clinical trial—called CLARITY—which found that the drug removed beta amyloid plaques in the brains of patients with early stage Alzheimer’s. The study was funded by pharmaceutical giants Biogen and Eisai, which developed the drug, and revealed that there was 27 percent less cognitive decline among patients who received lecanemab compared to those on the placebo.

“The question is whether the average patient in a clinic would notice that benefit,” Schrag says. “I don’t think they would.” More importantly, it’s the drug’s safety that concerns him. “I think we’re just beginning to see the tip of the iceberg with the risks.” But Schrag and others believe that beta amyloid proteins are only a small piece of a complicated puzzle and are not convinced they are central to delaying or arresting disease progression.

Lecanemab, on the other hand, shows some evidence of slowing disease progression, and it’s possible the benefits may increase if patients continue using it beyond 18 months, the length of the CLARITY trial, says clinical neurologist David Knopman at the Mayo Clinic in Rochester, Minnesota. “However, that data simply isn’t available at this point.” But like aducanumab, lecanemab comes with similar serious risks.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Paywall

✌😷

Looks like Mushroom

I'm guessing those you attempt to administer this to will forget why they are getting it in the first place.

Can you please not paywall an article about a potential cure to fucking alzheimers 🙄

'accelerated approval of a drug that promises' Here we go.🙄

Let me guess, side effect - death, 💊 to be produced in China. Tell me if I am mistaken.

I really hate having to sign up for crap I don't want.

I'm sorry I think I would have trouble using or believing a new drug that the 'FDA' approved. Nope

link is to paywalled article. Did a clinical trial take place?

The clinical trial results were pathetic. It’s going after a source that has shown to be false.

the patient looks very poorly!!

I bet the approval won't be as fast as the covid vaccine.

Let me guess it targets protein beta-amyloid. It’s all snake oil. 🐍

Isn't that article ironic? ... elonmusk jordanbpeterson thevivafrei

I seriously doubt that badda boom badda bing there is a pill that can cure Alzheimers without serious side effects. It's always the search for the magic pill.

well you take this drug or you get something worse than death. alzheimers is insanely horrible. people who had cases in their family know.

I want to be cyberbrain as soon as possible so I don't get Alzheimer's.🤔

Those oatmeal cookies look terrible

Sometimes I really feel like there are cures for diseases that exist but corporations make too much money off of these diseases so they’ll never be out on the market

I would love to read this, but I'm not subscribing. I'll get the story somewhere else.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 537. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

The regulatory maze behind health tech vaporwareFDA clearance is necessary but complicated.
Source: verge - 🏆 94. / 67 Read more »

FDA paused trials for experimental drugs more often in recent yearsThe Food and Drug Administration has increasingly exercised its power to delay drug companies' testing of experimental drugs in recent years, a possible byproduct of newer medical technologies that offer promise but may pose additional risks. neiltyson patrickbetdavid
Source: dcexaminer - 🏆 6. / 94 Read more »

A new FDA-approved Alzheimer's medicine slowed cognitive decline in patientsThe ​US FDA approved Leqembi, a new drug that is intended to slow down cognitive decline in patients who have mild or early-stage Alzheimer's disease. I thought I saw a report it also shrunk the brain.
Source: IntEngineering - 🏆 287. / 63 Read more »

Eton’s stock rallies as FDA reviews treatment for alcohol poisoningShares of Eton Pharmaceuticals Inc. jumped about 11% in premarket trading on Wednesday after the company said its experimental treatment for alcohol...
Source: MarketWatch - 🏆 3. / 97 Read more »